CD19-targeted universal CAR-T (UCAR-T)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-targeted universal CAR-T (UCAR-T), covering 2024-11-13 to 2024-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) [Phase 1]